Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
MR-107A02 by Viatris for Post-Operative Pain: Likelihood of Approval
MR-107A02 is under clinical development by Viatris and currently in Phase III for Post-Operative Pain. According to GlobalData, Phase III...
Meloxicam fast acting by Viatris for Post-Operative Pain: Likelihood of Approval
Meloxicam fast acting is under clinical development by Viatris and currently in Phase III for Post-Operative Pain. According to GlobalData,...
MR-139 by Viatris for Blepharitis: Likelihood of Approval
MR-139 is under clinical development by Viatris and currently in Phase III for Blepharitis. According to GlobalData, Phase III drugs...